13F reference period
Q3 2026
CUSIP: 30054Y107
13F reference period
Q3 2026
Institutions Reporting
70
Shares (Excl. Options)
Price
$8.26
The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
Latest holder context comes from 70 institutions filings for Q3 2026.
Security key
30054Y107
13F reference period
Q3 2026
13F holders
70
13D/G owners
6
CIK / CUSIP context first
Broader feeds
Open recent reporting periods for CUSIP 30054Y107:
13D/G owners
Large-stake holder rows connected to Schedule 13D/G evidence.
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| LSP 7 Cooperative UA | 15% | -6.2% | $114,491,976 | +$7,765,422 | 5,288,313 | +7.3% | LSP 7 Cooperatieve U.A. | 12 Feb 2026 |
| RA CAPITAL MANAGEMENT, L.P. | 8.5% | -12% | $28,865,710 | 3,494,638 | 0% | RA Capital Management, L.P. | 06 Nov 2026 | |
| Pivotal bioVenture Partners Fund I, L.P. | 11% | $69,158,608 | 3,435,599 | Nan Fung Group Holdings Limited | 31 Dec 2025 | |||
| Point72 Asset Management, L.P. | 6.7% | +28% | $20,105,501 | +$4,324,862 | 2,434,080 | +27% | Point72 Asset Management, L.P. | 30 Sep 2026 |
| Andera Partners | 3.9% | -35% | $17,204,996 | -$6,246,398 | 1,391,990 | -27% | Andera Partners | 30 Jun 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.3% | -62% | $7,036,413 | -$8,995,743 | 851,866 | -56% | T. Rowe Price Associates, Inc. | 30 Sep 2026 |
13F concentration
Largest 13F positions for this security by reported shares and value.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| EQT Fund Management S.a r.l. | 15% | 5,288,313 | 4.6% | $43,681,465 | |
| RA CAPITAL MANAGEMENT, L.P. | 9.6% | 3,494,638 | 0.29% | $28,865,710 | |
| Point72 Asset Management, L.P. | 6.7% | 2,434,080 | 0.03% | $20,105,501 | |
| Pivotal bioVenture Partners Investment Advisor LLC | 5.3% | 1,926,943 | 6.3% | $15,916,549 | |
| Defilade Capital Management, L.P. | 3.9% | 1,430,573 | 2% | $11,816,533 | |
| Vestal Point Capital, LP | 3.4% | 1,250,000 | 0.27% | $10,325,000 | |
| BAKER BROS. ADVISORS LP | 3.4% | 1,234,794 | 0.05% | $10,199,398 | |
| Kynam Capital Management, LP | 3.3% | 1,200,000 | 0.55% | $9,912,000 | |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.8% | 1,004,473 | 0% | $8,296,947 | |
| Qube Research & Technologies Ltd | 1.9% | 684,713 | 0.01% | $5,655,729 | |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1.6% | 594,027 | 0.6% | $4,906,663 | |
| GEODE CAPITAL MANAGEMENT, LLC | 1.3% | 467,271 | 0% | $3,860,818 | |
| Velan Capital Investment Management LP | 1.3% | 456,255 | 3.6% | $3,768,666 | |
| SPHERA FUNDS MANAGEMENT LTD. | 1.1% | 390,632 | 0.49% | $3,226,620 | |
| GREAT POINT PARTNERS LLC | 0.89% | 325,000 | 0.7% | $2,684,500 | |
| GOLDMAN SACHS GROUP INC | 0.83% | 301,400 | 0% | $2,489,564 | |
| Trexquant Investment LP | 0.78% | 284,954 | 0.01% | $2,353,720 | |
| STATE STREET CORP | 0.74% | 267,910 | 0% | $2,212,937 | |
| TWO SIGMA INVESTMENTS, LP | 0.72% | 259,835 | 0% | $2,146,237 | |
| RTW INVESTMENTS, LP | 0.57% | 208,071 | 0.02% | $1,718,666 | |
| SummitTX Capital, L.P. | 0.56% | 201,714 | 0.04% | $1,666,158 | |
| XTX Topco Ltd | 0.46% | 166,671 | 0.02% | $1,376,702 | |
| ORBIMED ADVISORS LLC | 0.44% | 161,000 | 0.02% | $1,329,860 | |
| Y-Intercept (Hong Kong) Ltd | 0.44% | 158,813 | 0.03% | $1,311,795 | |
| VANGUARD FIDUCIARY TRUST CO | 0.42% | 152,823 | 0% | $1,262,318 |
Quarter history
Holder count, reported shares/value, and median price by quarter.
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 28,776,369 | $237,698,161 | -$28,261,969 | $8.26 | 70 |
| 2026 Q2 | 34,570,369 | $462,177,708 | -$34,339,695 | $13.29 | 104 |
| 2026 Q1 | 34,576,739 | $793,406,919 | +$167,246,545 | $22.99 | 84 |
| 2025 Q4 | 27,200,904 | $465,685,578 | +$403,679,610 | $17.12 | 59 |